Is anti-Müllerian hormone a marker of acute cyclophosphamide-induced ovarian follicular destruction in mice pretreated with cetrorelix?

Fertility and Sterility

Volumn 96, Issue 1, 2011, Pages

  Browne, Hyacinth N ^a,b   Moon, Kimberly S ^a   Mumford, Sunni L ^a   Schisterman, Enrique F ^a   Decherney, Alan H ^a   Segars, James H ^a   Armstrong, Alicia Y ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b SIRM Westchester   (United States)

Author keywords

anti M llerian hormone; cyclophosphamide; DNA damage; GnRH antagonist; primordial follicles

Indexed keywords

CETRORELIX; CYCLOPHOSPHAMIDE; MUELLERIAN INHIBITING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DESTRUCTION; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GERM CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79959861453     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.04.008     Document Type: Article

References (35)

1. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M.J. Thun Cancer statistics, 2003 CA Cancer J Clin 53 2003 5 26 (Pubitemid 36163619)
2. M. Weintraub, E. Gross, A. Kadari, V. Ravitsky, A. Safran, and N. Laufer Should ovarian cryopreservation be offered to girls with cancer Pediatr Blood Cancer 48 2007 4 9 (Pubitemid 44871585)
3. K. Ataya, L.V. Rao, E. Lawrence, and R. Kimmel Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys Biol Reprod 52 1995 365 372
4. Z. Blumenfeld, I. Avivi, S. Linn, R. Epelbaum, M. Ben-Shahar, and N. Haim Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy Hum Reprod 11 1996 1620 1626 (Pubitemid 26318897)
5. Z. Blumenfeld, E. Dann, I. Avivi, R. Epelbaum, and J.M. Rowe Fertility after treatment for Hodgkin's disease Ann Oncol 13 Suppl 1 2002 138 147 (Pubitemid 34567418)
6. Z. Blumenfeld, D. Shapiro, M. Shteinberg, I. Avivi, and M. Nahir Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy Lupus 9 2000 401 405 (Pubitemid 30487421)
7. D. Meirow, G. Assad, J. Dor, and J. Rabinovici The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice Hum Reprod 19 2004 1294 1299 (Pubitemid 38807699)
8. H. Sauer, and P. Gates The preservation of fertility in chemotherapy patients: the use of a gonadotropin releasing hormone antagonist (GnRH-antagonist) cetrorelix for ovarian down-regulation prior to chemotherapy [Abstract] J Soc Gynecol Investig 13 2006 170A 171A
9. E.A. McGee, and A.J. Hsueh Initial and cyclic recruitment of ovarian follicles Endocrinol Rev 21 2000 200 214 (Pubitemid 32275595)
10. J. Rabinovici, and R.B. Jaffe Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads Endocrinol Rev 11 1990 532 557
11. R. Resnik, A.P. Killam, F.C. Battaglia, E.L. Makowski, and G. Meschia The stimulation of uterine blood flow by various estrogens Endocrinology 94 1974 1192 1196
12. T. Dada, O. Salha, V. Allgar, and V. Sharma Utero-ovarian blood flow characteristics of pituitary desensitization Hum Reprod 16 2001 1663 1670 (Pubitemid 32761747)
13. E.H. Yu Ng, C. Chi Wai Chan, O.S. Tang, W. Shu Biu Yeung, and P. Chung Ho Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation Hum Reprod 19 2004 2811 2815 (Pubitemid 40028952)
14. R.M. Janssens, L. Brus, D.J. Cahill, J.A. Huirne, J. Schoemaker, and C.B. Lambalk Direct ovarian effects and safety aspects of GnRH agonists and antagonists Hum Reprod Update 6 2000 505 518
15. C. Seguin, G. Pelletier, D. Dube, and F. Labrie Distribution of luteinizing hormone-releasing hormone receptors in the rat ovary Regul Pept 4 1982 183 190 (Pubitemid 13246255)
16. T. Yano, N. Yano, H. Matsumi, Y. Morita, O. Tsutsumi, and A.V. Schally Effect of luteinizing hormone-releasing hormone analogs on the rat ovarian follicle development Horm Res 48 Suppl 3 1997 35 41 (Pubitemid 27352731)
17. P.B. Jones, and A.J. Hsueh Regulation of ovarian 20 alpha-hydroxysteroid dehydrogenase by gonadotropin releasing hormone and its antagonist in vitro and in vivo J Steroid Biochem 14 1981 1169 1175 (Pubitemid 12218477)
18. P.B. Jones, and A.J. Hsueh Direct effects of gonadotropin releasing hormone and its antagonist upon ovarian functions stimulated by FSH, prolactin, ans LH Biol Reprod 24 1981 747 759 (Pubitemid 11043200)
19. S.A. Pangas Growth factors in ovarian development Semin Reprod Med 25 2007 225 234 (Pubitemid 47047906)
20. A.L. Durlinger, J.A. Visser, and A.P. Themmen Regulation of ovarian function: the role of anti-Mullerian hormone Reproduction 124 2002 601 609 (Pubitemid 35402334)
21. P.G. Knight, and C. Glister TGF-beta superfamily members and ovarian follicle development Reproduction 132 2006 191 206 (Pubitemid 44274724)
22. J.A. Visser, and A.P. Themmen Anti-Mullerian hormone and folliculogenesis Mol Cell Endocrinol 234 2005 81 86
23. M.E. Kevenaar, M.F. Meerasahib, P. Kramer, B. van de Lang-Born, F. de Jong, and N. Groome Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice Endocrinology 147 2006 3228 3234 (Pubitemid 43901114)
24. R.D. van Beek, M.M. van den Heuvel-Eibrink, J.S. Laven, F. de Jong, A. Themmen, and F. Hakvoort-Cammel Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood J Clin Endocrinol Metab 92 2007 3869 3874 (Pubitemid 47607635)
25. A.L. Durlinger, P. Kramer, B. Karels, F. de Jong, J. Ullenbroek, and J. Grootegoed Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary Endocrinology 140 1999 5789 5796 (Pubitemid 30645368)
26. R.R. Behringer, R.L. Cate, G.J. Froelick, R.D. Palmiter, and R.L. Brinster Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance Nature 345 1990 167 170
27. D. Meirow, H. Lewis, D. Nugent, and M. Epstein Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool Hum Reprod 14 1999 1903 1907 (Pubitemid 29358724)
28. D. Meirow Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers Leuk Lymphoma 33 1999 65 76 (Pubitemid 29116395)
29. Y.H. Huang, X.J. Zhao, Q.H. Zhang, and X.Y. Xin The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis Gynecol Oncol 112 2009 409 414
30. C. Celik-Ozenci, G. Akkoyunlu, E.T. Korgun, B. Savas, and R. Demir Expressions of VEGF and its receptors in rat corpus luteum during interferon alpha administration in early and pseudopregnancy Mol Reprod Dev 67 2004 414 423 (Pubitemid 38298715)
31. M.A. Edson, A.K. Nagaraja, and M.M. Matzuk The mammalian ovary from genesis to revelation Endocrinol Rev 30 2009 624 712
32. D.R. Mattison, L. Chang, S.S. Thorgeirsson, and K. Shiromizu The effects of cyclophosphamide, azathioprine, and 6-mercaptopurine on oocyte and follicle number in C57BL/6N mice Res Commun Chem Pathol Pharmacol 31 1981 155 161 (Pubitemid 11173803)
33. S.K. Sahambi, J.A. Visser, A.P. Themmen, L.P. Mayer, and P.J. Devine Correlation of serum anti-Mullerian hormone with accelerated follicle loss following 4-vinylcyclohexene diepoxide-induced follicle loss in mice Reprod Toxicol 26 2008 116 122
34. D.R. Plowchalk, and D.R. Mattison Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. Effects on ovarian structure and function Reprod Toxicol 6 1992 411 421
35. D. Meirow, and D. Nugent The effects of radiotherapy and chemotherapy on female reproduction Hum Reprod Update 7 2001 535 543 (Pubitemid 33069611)